NCT05254223 (AIDE-RAP) is a NA clinical trial of Antiinflammatory Diet in Rheumatoid Arthritis, sponsored by Jose manuel Lou Bonafonte.

Who is sponsoring NCT05254223?

NCT05254223 is sponsored by Jose manuel Lou Bonafonte.

What drugs are being tested in NCT05254223?

Interventions in NCT05254223: Antiinflammatory Diet, Control Diet.

What condition does NCT05254223 study?

NCT05254223 studies Rheumatoid Arthritis.

Is NCT05254223 still recruiting?

NCT05254223 is currently completed. Last updated 24 February 2022.

Last reviewed 2022-02-24 · How we verify

NCT05254223: AIDE-RAP

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Anti-Inflammatory Diet Effect in Rheumatoid Arthritis Patients

Completed NA Last updated 24 February 2022

What this trial tests

NA trial testing Antiinflammatory Diet in Rheumatoid Arthritis in 29 participants. Completed in 19 June 2018.

Timeline

12 December 2016

Primary endpoint
19 October 2017

19 June 2018

Quick facts

Lead sponsor	Jose manuel Lou Bonafonte
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	supportive care
Enrollment	29
Start date	12 December 2016
Primary completion	19 October 2017
Estimated completion	19 June 2018

Drugs / interventions tested

Antiinflammatory Diet
Control Diet

Conditions studied

Rheumatoid Arthritis — all drugs for Rheumatoid Arthritis →

Sponsor

Jose manuel Lou Bonafonte

Who can join

Adults 18 to 80, any sex, with Rheumatoid Arthritis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The current study pretends to clarify, whether or not a healthy anti inflammatory diet improves different health-related outcomes in participants with rheumatoid arthritis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Rheumatoid Arthritis

Currently open trials in the same condition.

NCT07433335 — A Study to Assess the Safety and Tolerability of SR-878 in Patients With Rheumatoid Arthritis · Phase 1 · recruiting
NCT07491016 — Efficacy and Safety of Telitacicept Combined With Baricitinib for Refractory Rheumatoid Arthritis · recruiting
NCT07171983 — A Study to Evaluate the Safety, Tolerability, and Drug Levels of BMS-986454 in Participants With Rheumatoid Arthritis · Phase 1 · recruiting
NCT07246096 — Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA U CAR-T Cell Injection for the Treatment of Rel · EARLY_PHASE1 · recruiting
NCT07363590 — A Clinical Study of MK-1045 in People With Lupus or Rheumatoid Arthritis (MK-1045-004) · Phase 1 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05254223 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Jose manuel Lou Bonafonte
Last refreshed: 24 February 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05254223.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing